Difficulty: Medium
Average Score: 68%
Practice
All the following are long-term complications of intravenous cyclophosphamide EXCEPT
Correct answer
B
Rationale
The correct answer is B) bladder cancer. Intravenous cyclophosphamide is a chemotherapeutic agent that is associated with various long-term complications due to its toxicity. Bladder cancer is not a common long-term complication associated with cyclophosphamide use.
A) Bone marrow suppression is a well-known side effect of cyclophosphamide. It can lead to decreased production of blood cells, making patients more susceptible to infections, anemia, and bleeding.
C) Leukemia is another potential long-term complication of cyclophosphamide use. Prolonged exposure to this drug can increase the risk of developing secondary cancers, including leukemia.
D) Infertility is a significant concern with cyclophosphamide use, especially in women. This drug can cause damage to the ovaries, leading to infertility or premature menopause.
Educational context: Understanding the potential long-term complications of medications used in pediatric patients is crucial for pediatric nurses. It allows them to monitor for signs and symptoms, provide appropriate education to patients and families, and collaborate with the healthcare team to minimize risks and manage complications effectively.
A) Bone marrow suppression is a well-known side effect of cyclophosphamide. It can lead to decreased production of blood cells, making patients more susceptible to infections, anemia, and bleeding.
C) Leukemia is another potential long-term complication of cyclophosphamide use. Prolonged exposure to this drug can increase the risk of developing secondary cancers, including leukemia.
D) Infertility is a significant concern with cyclophosphamide use, especially in women. This drug can cause damage to the ovaries, leading to infertility or premature menopause.
Educational context: Understanding the potential long-term complications of medications used in pediatric patients is crucial for pediatric nurses. It allows them to monitor for signs and symptoms, provide appropriate education to patients and families, and collaborate with the healthcare team to minimize risks and manage complications effectively.